{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-022604","form_type":"8-K","ticker":"RNLXY","cik":"0001811115","company_name":"Renalytix plc","filed_at":"2024-02-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.629987+00:00","generated_at":"2026-06-05T07:13:47.671183+00:00","sec_items":["7.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Renalytix secures 10-year US government contract; Medicare coverage decision pending","bullets":["KidneyIntelX.dkd added to 10-year GWAC through GSA, covering VA, DoD, IHS, at $950/result.","NGS holds Open Public Meeting on proposed coverage policy DL39726; final LCD expected FY2024.","Effective Jan 1, 2024, test priced at $950 on CMS CLFS for three years.","These advancements expected to enable insurance coverage for 10M of 14M FDA-indicated patients."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-022604","json":"https://secwatch.observer/filing/0000950170-24-022604.json","markdown":"https://secwatch.observer/filing/0000950170-24-022604.md","text":"https://secwatch.observer/filing/0000950170-24-022604.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1811115/000095017024022604/0000950170-24-022604-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1811115/000095017024022604/rnlx-20240229.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T07:13:47.671183+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}